Visualization hub for genomics data exploration and translational discovery
Visualization hub for genomics data exploration and translational discovery
批准号:
9351489
负责人:
Eric Collisson
金额:
$87.1万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-13 至 2021-08-31
关键词:
Automobile DrivingBig DataBioinformaticsBiologicalCancer PatientCause of DeathClinicalClinical ResearchClinical TreatmentClinical TrialsCommunitiesComputersDNA SequenceDNA copy numberDataData SetDevelopmentDiseaseDisease ProgressionEnsureEnvironmentEvolutionFutureGenome Data Analysis NetworkGenomic medicineGenomicsGoalsImageryImmune responseImmunologicsImmunotherapyIndividualInstitutionInternationalInvestigationKnowledgeLibrariesMalignant NeoplasmsMalignant neoplasm of pancreasMeasuresMedicineMetastatic MelanomaMolecularOncoproteinsOnline SystemsPatient-Focused OutcomesPatientsPerformancePlayPrincipal InvestigatorProcessProteinsRNAReceptors, Antigen, B-CellResearchResearch PersonnelResearch Project GrantsResistanceRoleScientistSecureStructureSystemT-Cell ReceptorTestingTherapeuticTimeVisualVisualization softwareWorkanticancer researchbasecancer carecancer genomecancer genomicscancer initiationcancer therapycloud platformdata accessdata hubdata resourcedata visualizationdesigneffective therapyexperienceexperimental studygenome-widegenomic dataimmunogenicimprovedinteroperabilityknowledge translationmeetingsneglectnext generationnovelnovel therapeuticsopen sourcepersonalized medicinepetabyteportabilityprecision medicineprogramsrepositoryresponsesmall moleculesoftware repositorysuccesssymposiumtherapy resistanttooltranscriptometreatment responsetumorusabilityuser-friendlyweb interfaceworking group
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
Large NCI clinical trials and research projects have been generating data on cancer genomes at an
unprecedented rate, elucidating the mechanisms of cancer initiation and evolution, as well as resistance to
therapy. To fully utilize this comprehensive data resource, which has exceeded a petabyte (1015 bytes) of data,
the scientific community needs deep, user-friendly interactive computer visualizations of the data. These will
empower investigators to discover the molecular processes driving each patient's cancer, and to identify
potential translations of this knowledge into new therapies, ultimately advancing both our knowledge of cancer
mechanisms and patient outcomes.
We propose to develop a web-based Data Hub and Viz Hub platform to allow researchers to visualize the
richness of the NCI's cancer genomics data from a single web interface. Visualizations will be composed of a
set of “bio-centric” views developed by the bioinformatics community and made available in BioJS, an open-
source repository of tools to represent biological data. This will establish a new paradigm of web-based
biological data visualization development by way of sharable and reusable modular open source components.
To initiate the Viz Hub platform, we will integrate seven popular 3rd-party bioinformatics visualizations into the
existing UCSC Xena Browser utilizing a plug-and-play framework. We will then work closely with several
clinical labs to develop two new translational visualizations for the next generation of genomic medicine. One
will be a Longitudinal Omics Integrator, giving researchers a highlighted overview of a patient while drilling
down into genomic and functional data collected throughout treatment. Another will help researchers
investigate responses to various new types of immunotherapy, which promise to revolutionize cancer
treatment. This Immuno-Tracker and Immunoediting Viewer will show how immunogenic neoantigens, T-cell
receptors, and B-cell receptors change over disease progression and in response to treatment.
The visualization needs of the scientific community, NCI's Genomic Data Analysis Network, and Disease
Working groups will be fully supported through our system of public and restricted Data Hubs. Our high-
performance Data Hubs will be easy to install on a diverse range of computing environments. Users will be
able to integrate public and restricted data, from large consortia and individual researchers (including their own
labs), seamlessly on our web-based Viz Hub. Our commitment to bioinformatics community standards, such as
GA4GH and BioJS, ensures that our contributions will be interoperable. Our designs will be vetted by users
through testing in tumor boards and at designated booths at international cancer meetings. This will ensure
that our platform will effectively serve researchers, biologists and clinicians now and into the future of precision
medicine.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Optimizing Pancreatic Cancer Management with Next Generation Imaging and Liquid Biopsy
-
批准号:10376196
-
项目类别:
-
资助金额:$59.65万
-
财政年份:2021
-
负责人:Eric Collisson
-
依托单位:
Optimizing Pancreatic Cancer Management with Next Generation Imaging and Liquid Biopsy
-
批准号:10584523
-
项目类别:
-
资助金额:$59.83万
-
财政年份:2021
-
负责人:Eric Collisson
-
依托单位:
Understanding Efficacy and Fe(II)-Promoted Activation of 1,2,4-Trioxolanes in Cancer
-
批准号:10374172
-
项目类别:
-
资助金额:$62.66万
-
财政年份:2021
-
负责人:Eric Collisson
-
依托单位:
Understanding Efficacy and Fe(II)-Promoted Activation of 1,2,4-Trioxolanes in Cancer
-
批准号:10622460
-
项目类别:
-
资助金额:$62.51万
-
财政年份:2021
-
负责人:Eric Collisson
-
依托单位:
The structural and functional basis of MET exon 14 activation and acquired drug resistance
-
批准号:9754544
-
项目类别:
-
资助金额:$40.81万
-
财政年份:2019
-
负责人:Eric Collisson
-
依托单位:
The structural and functional basis of MET exon 14 activation and acquired drug resistance
-
批准号:9892984
-
项目类别:
-
资助金额:$40.99万
-
财政年份:2019
-
负责人:Eric Collisson
-
依托单位:
The structural and functional basis of MET exon 14 activation and acquired drug resistance
-
批准号:10375379
-
项目类别:
-
资助金额:$40.24万
-
财政年份:2019
-
负责人:Eric Collisson
-
依托单位:
Optimizing Treatment Approaches to Lung Cancers Harboring MET Exon 14 mutations
-
批准号:9891979
-
项目类别:
-
资助金额:$44.51万
-
财政年份:2019
-
负责人:Eric Collisson
-
依托单位:
Optimizing Treatment Approaches to Lung Cancers Harboring MET Exon 14 mutations
-
批准号:9763138
-
项目类别:
-
资助金额:$43.3万
-
财政年份:2019
-
负责人:Eric Collisson
-
依托单位:
Optimizing Treatment Approaches to Lung Cancers Harboring MET Exon 14 mutations
-
批准号:10589867
-
项目类别:
-
资助金额:$32.85万
-
财政年份:2019
-
负责人:Eric Collisson
-
依托单位:
The structural and functional basis of MET exon 14 activation and acquired drug resistance
-
批准号:10580077
-
项目类别:
-
资助金额:$40.24万
-
财政年份:2019
-
负责人:Eric Collisson
-
依托单位:
Optimizing Treatment Approaches to Lung Cancers Harboring MET Exon 14 mutations
-
批准号:10372938
-
项目类别:
-
资助金额:$40.1万
-
财政年份:2019
-
负责人:Eric Collisson
-
依托单位:
Genomics and Functional Characterization of NF1-mutated Lung Cancer
-
批准号:10176422
-
项目类别:
-
资助金额:$53.67万
-
财政年份:2018
-
负责人:Eric Collisson
-
依托单位:
Genomics and Functional Characterization of NF1-mutated Lung Cancer
-
批准号:10396561
-
项目类别:
-
资助金额:$53.53万
-
财政年份:2018
-
负责人:Eric Collisson
-
依托单位:
Tailoring Therapy to Pancreatic Cancer Subtypes
-
批准号:10453659
-
项目类别:
-
资助金额:$33.94万
-
财政年份:2018
-
负责人:Eric Collisson
-
依托单位:
Tailoring Therapy to Pancreatic Cancer Subtypes
-
批准号:10239021
-
项目类别:
-
资助金额:$34.9万
-
财政年份:2018
-
负责人:Eric Collisson
-
依托单位:
Visualization hub for genomics data exploration and translational discovery
-
批准号:9210825
-
项目类别:
-
资助金额:$88.9万
-
财政年份:2016
-
负责人:Eric Collisson
-
依托单位:
Visualization hub for genomics data exploration and translational discovery
-
批准号:9756153
-
项目类别:
-
资助金额:$72.38万
-
财政年份:2016
-
负责人:Eric Collisson
-
依托单位:
A Genetically Defined System to Identify Factors Essential for KRas Oncogenesis
-
批准号:8788392
-
项目类别:
-
资助金额:$18.03万
-
财政年份:2014
-
负责人:Eric Collisson
-
依托单位:
Crucial Microenvironmental Cofactors for Pancreatic Cancer Pathogenesis
-
批准号:8760177
-
项目类别:
-
资助金额:$30.89万
-
财政年份:2014
-
负责人:Eric Collisson
-
依托单位:
国内基金
海外基金
Scalable Learning and Optimization: High-dimensional Models and Online Decision-Making Strategies for Big Data Analysis
-
批准号:--
-
项目类别:合作创新研究团队
-
资助金额:--
-
批准年份:2024
-
负责人:姚韬
-
依托单位: